Canadian company Deep Genomics has announced that its AI-based drug discovery platform has identified both a target and drug candidate for Wilson's disease.
from Future Timeline | Latest Updates | Technology | Singularity | 2020 | 2050 | 2100 | 2150 | 2200 | 2.. https://ift.tt/2nb3JzY
via Digital Media
No comments:
Post a Comment